Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population
Chronic lymphocytic leukemia (CLL) is characterized by the proliferation and accumulation of clonal B lymphocytes with a characteristic immunophenotype. Although historically treated with chemoimmu...
Authors
- Neil E. Kay (ORCID: https://orcid.org/0000-0002-5951-5055)
- Mazie Tsang (ORCID: https://orcid.org/0000-0003-1215-4210)
- Lauren Pomerantz (ORCID: https://orcid.org/0000-0002-2917-961X)
- S. Parikh
- Paul Joseph Hampel (ORCID: https://orcid.org/0000-0003-1292-3024)
- Saad J. Kenderian
- S E Slager
- Amber B. Koehler (ORCID: https://orcid.org/0000-0002-2539-040X)
- Cinthya J. Zepeda‐Mendoza (ORCID: https://orcid.org/0000-0002-0434-4965)
- Talal Hilal (ORCID: https://orcid.org/0000-0001-8249-4128)
- Kari G. Rabe (ORCID: https://orcid.org/0000-0002-7313-1875)
- Ricardo D. Parrondo (ORCID: https://orcid.org/0000-0002-9314-9933)
- Esteban Braggio
- Catherine C. Wagner
- Jose F. Leis
- Lindsey E. Roeker
- Yucai Wang
- Min Shi
- Amy L. Behnken
- Rachel J. Bailen
- Curtis A. Hanson
- Susan M. Schwager
Institutions
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- St. Luke's Hospital (US)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1080/10428194.2026.2687633
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00